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Background: G-protein-coupled receptors (GPCRs), in the form of monomers or homodimers that bind heterotrimeric
G proteins, are fundamental in the transfer of extracellular stimuli to intracellular signaling pathways. Different
GPCRs may also interact to form heteromers that are novel signaling units. Despite the exponential growth in
the number of solved GPCR crystal structures, the structural properties of heteromers remain unknown.
Results: We used single-particle tracking experiments in cells expressing functional adenosine A1-A2A receptors fused
to fluorescent proteins to show the loss of Brownian movement of the A1 receptor in the presence of the
A2A receptor, and a preponderance of cell surface 2:2 receptor heteromers (dimer of dimers). Using computer
modeling, aided by bioluminescence resonance energy transfer assays to monitor receptor homomerization
and heteromerization and G-protein coupling, we predict the interacting interfaces and propose a quaternary
structure of the GPCR tetramer in complex with two G proteins.
Conclusions: The combination of results points to a molecular architecture formed by a rhombus-shaped
heterotetramer, which is bound to two different interacting heterotrimeric G proteins (Gi and Gs). These novel
results constitute an important advance in understanding the molecular intricacies involved in GPCR function.
Keywords: GPCR, Heterotetramer, Heterotrimeric G protein, Single-particle tracking, BRET, Molecular modelingBackground
G-protein-coupled receptor (GPCR) oligomerization is
heavily supported by recent biochemical and structural
data [1–6]. Optical-based techniques are instrumental in
studying the dynamics and organization of receptor
complexes in living cells [7]. For instance, total internal
reflection fluorescence microscopy shows that 30 % of
muscarinic M1 receptors exist as dimers (with no
evidence of higher oligomers) that undergo interconver-
sion with monomers on a timescale of seconds [8]. Simi-
larly, the β1-adrenergic receptors (β1-AR) are expressed as
a mixture of monomers and dimers whereas β2-adrenergic
receptors (β2-AR) have a tendency to form dimers and* Correspondence: p.mccormick@uea.ac.uk; rfranco123@gmail.com
†Equal contributors
1Centro de Investigación Biomédica en Red sobre Enfermedades
Neurodegenerativas (CIBERNED), Madrid, Spain
Full list of author information is available at the end of the article
© 2016 Navarro et al. Open Access This articl
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zehigher-order oligomers [9]. Moreover, the monomer-dimer
equilibrium of the chemoattractant N-formyl peptide
receptor at a physiological level of expression lies within a
timescale of milliseconds [10]. Together, these studies in
heterologous systems show that a given GPCR is present
in a dynamic equilibrium between monomers, dimers, and
higher-order oligomers.
Studies in a broad spectrum of GPCRs [11–14] show
that these receptors may form heteromers. GPCR
heteromers are defined as novel signaling units with
functional properties different from homomers and they
represent a completely new field of study [15]. Innovative
crystallographic techniques have permitted researchers to
obtain crystal structures of GPCR families A, B, C, and F,
bound to either agonists, antagonists, inverse agonists or
allosteric modulators; in the form of monomers or
homo-oligomers; and in complex with a G protein ore is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Navarro et al. BMC Biology  (2016) 14:26 Page 2 of 12with a ß-arrestin [16]. However, crystal structures of
GPCR heteromers have not yet been obtained. Here,
we propose a quaternary structure of a heteromer,
taking into account the molecular stoichiometry and
the interacting G proteins. Adenosine A1-A2A recep-
tor (A1R-A2AR) complexes constitute a paradigm in
the GPCR heteromer field because A1R is coupled to
Gi and A2AR to Gs; that is, they transduce opposite
signals in cyclic adenosine monophosphate (cAMP)-
dependent intracellular cascades. First described as a
concentration-sensing device in striatal glutamatergic
neurons [17], the A1R-A2AR heteromer is thought to
function as a Gs/Gi-mediated switching mechanism by
which low and high concentrations of adenosine
inhibit and stimulate, respectively, glutamate release
[17, 18]. The structural basis of this switch is key to un-
derstanding heteromer function and the biological advan-
tage behind the GPCR heteromerization phenomenon.
Here, we have devised the molecular architecture of
the adenosine A1R-A2AR heteromer in complex with
G proteins using a combination of microscope-based
single-particle tracking, molecular modeling, and
energy transfer assays in combination with molecular
complementation. The results point to A1 and A2A
receptors organizing into a rhombus-shaped heterote-
tramer that couples to Gi and Gs. The overall struc-
ture is very compact and provides interacting
interfaces for GPCRs and for G proteins.
Results and discussion
Reciprocal restriction of adenosine receptor motion in the
plasma membrane
To examine the dynamics of A1R-A2AR heteromers in
the plasma membrane of a living cell, the motion of the
receptors tagged with fluorescent proteins (A1R-green
fluorescent protein [GFP] or A2AR-mCherry) was mea-
sured by real-time single-particle tracking (SPT) (Fig. 1).
Examples of fluorescent images and individual particle
trajectories are shown in Additional file 1: Figure S1.
Analysis of data corresponding to 500 A1R-GFP particles
showed a linear relationship between the mean square
displacement (MSD) versus time lag in the trajectories
of up to 1600 single fluorescent particles (Fig. 1a, c).
This is typical for Brownian diffusion, indicating a lack
of restrictions in A1R-GFP motion. Co-expression of
A2AR-mCherry (Fig. 1b) led to a reduction in the lateral
mobility of A1R-GFP, which became confined to plasma
membrane regions of 0.461 ± 0.004 μm in diameter. Its
diffusion coefficient decreased from 0.381 ± 0.002 μm2/s
to 0.291 ± 0.003 μm2/s (p = 0.002, one-tailed t-test).
Similarly, A1R-GFP also decreased the A2AR-mCherry
diffusion coefficient from 0.317 ± 0.002 μm2/s to 0.143 ±
0.005 μm2/s (p < 0.0001) (Fig. 1d–f ). A2AR moved within
a confinement zone of 0.941 ± 0.007 μm in diameter thatwas reduced to 0.360 ± 0.001 μm (p < 0.0001) when both
receptors were co-expressed. We conclude from these
mobility comparisons that reciprocally restricted motion
of the individual receptor particles must be due to A1R-
A2AR receptor-receptor interactions.
Stoichiometry of A1 and A2A receptor heterocomplexes
The stoichiometry of the fluorescent receptors on the
cell surface can be calculated from the brightness distri-
bution of the individual particles [19] (see “Methods”).
In cells expressing A1R-GFP, we found the majority of
clusters to consist of either two (~47 %) or four (~34 %) re-
ceptors, and clusters with one or three receptors were
scarce (~10 % and ~9 %, respectively) (Additional file 2:
Figure S2A and black bars in Additional file 2: Figure S2C).
In the case of A2AR-mCherry, the stoichiometry
analysis showed that the clusters mostly expressed trimers
(45 %), with dimers (29 %) and tetramers (12 %) the
second and third most common populations (Additional
file 2: Figure S2D and black bars in Additional file 2:
Figure S2F). Remarkably, this stoichiometry for either A1
or A2A receptors was altered when the partner receptor
was also expressed. In cells co-expressing A1R-GFP and
A2AR-mCherry, the dimer population increased (57 % for
A1R-GFP and 49 % for A2AR-mCherry, blue bars in
Additional file 2: Figures S2C, F) and became the predom-
inant species (Additional file 2: Figures S2B, C, E, F).
In order to focus the analysis on heteromer com-
plexes, we identified clusters containing both recep-
tors (individual yellow dots in Fig. 1g, displaying both
GFP and mCherry fluorescence). In ~1000 analyzed co-
localized clusters that consisted of a mixture of A1-GFP
and A2A-Cherry (yellow dots in Fig. 1g), we found a
similar high amount of dimers of A1R (75 %, left panel
in Fig. 1h and green bar in Fig. 1i) and A2AR (74 %, right
panel in Fig. 1h and red bar in Fig. 1i). Trimers and
tetramers of A1R, and monomers and tetramers of
A2AR, were in the minority or negligible (see Fig. 1h, i).
In summary, given that the percentage of dimers of
either A1R-GFP or A2AR-mCherry in the yellow dots
(which show co-localization of the two receptors) was
similar and high (~75 %), the heterotetramer containing
two A1Rs and two A2ARs must have been the most pre-
dominant species. To our knowledge, this is the first
stoichiometry data for a GPCR heteromer in living cells.
Arrangement of G proteins interacting with A1 and A2A
receptors
Monomeric GPCRs are capable of activating G proteins
[20]. However, recent findings suggest that one GPCR
homodimer bound to a single G protein may be a com-
mon functional unit [21]. Thus, an emerging question is
how G proteins couple to GPCR heteromers. Because
A1R selectively couples to Gi and A2AR to Gs [22], the
Fig. 1 Cell surface mobility of A1R-GFP and A2AR-mCherry. Individual trajectories of particles containing GFP fused to the C-terminus of
A1R (A1-GFP) (a and b) or mCherry fused to the C-terminus of A2AR (A2A-mCherry) (d and e) on HEK-293T cells expressing A1-GFP (a), A2A-mCherry
(d) or both (b and e). The trajectory and the fluorescence intensity of the individual particles were recorded over time using total internal reflection
microscopy (TIRFM) and an electron multiplying charged-coupled device (EMCCD) camera recording. Receptor motion was determined by plotting
(versus time lag) the mean square displacement (MSD) of A1-GFP (c) in the absence (black line) or presence of A2A-mCherry (blue line), or A2A-mCherry
(f) in the presence (black line) or presence of A1-GFP (blue line). Data sets were fitted to mathematical models of free and confined diffusion for A1R
and A2AR respectively. g Co-localization of A1-GFP and A2A-mCherry is observed (yellow dots). Scale bar: 100 nm. h Distribution of the fluorescence
signal of A1-GFP (left) and A2A-mCherry (right) within co-localized receptors (yellow dots in g). Curves approximately delineate the number of monomers,
dimers, or trimers within the co-localized complex. i Stoichiometry analysis performed for co-localized A1-GFP and A2A-mCherry receptor particles
co-expressed in HEK-293T cells (yellow dots in g). Green corresponds to A1-GFP and red to A2A-mCherry
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may couple to the A1R-A2AR heterotetramer. To test
this hypothesis, we used bioluminescence resonance
energy transfer (BRET) assays [23]. In agreement with
the SPT experiments (see above), homodimers and
heterodimers were detected by BRET assays in cells
expressing A1R fused with Renilla luciferase (A1R-Rluc)
or yellow fluorescent protein (A1R-YFP) (Fig. 2a), A2AR-
Rluc and A2AR-YFP (Fig. 2b), or A1R-Rluc and A2AR-
YFP (Fig. 2e). Neither A1R-Rluc nor A2AR-YFP inter-
acted with the ghrelin receptor 1a fused to YFP (GHS1a-
YFP), used as a control as a protein unable to directly
interact with these adenosine receptors (Fig. 2a, b). In
order to test the presence of the two G proteins in the
heterotetramer, we transfected cells with minigenes that
code for peptides blocking either Gi or Gs binding to
GPCRs [24]. In addition, cells were treated with pertus-
sis or cholera toxins that catalyze ADP-ribosylation of Gi
or Gs. Clearly, treating cells with pertussis toxin, or
expressing the minigene-coded peptide that blocks αicoupling, reduced the value of BRETmax for A1R-A1R
homodimers (Fig. 2a) and for A1R-A2AR heterodimers
(Fig. 2e) but not for A2AR-A2AR homodimers (Fig. 2b).
This indicates that Gi is coupled to A1R in both the
homodimer and the heterodimer. Similarly, blocking Gs-
receptor interaction using cholera toxin or a minigene-
coded peptide that blocks αS coupling reduced BRETmax
for A2AR-A2AR homodimers (Fig. 2b) and for A1R-A2AR
heterodimers (Fig. 2e) but not for A1R-A1R homodimers
(Fig. 2a). Interestingly, BRET curves showed sensitivity
to both cholera and pertussis toxins in cells expressing
either A1R-Rluc-A1R-YFP and A2AR (Fig. 2c) or A2AR-
Rluc-A2AR-YFP and A1R (Fig. 2d). Functionality of
constructs and controls in cells expressing minigenes,
and in cells expressing the ghrelin GHS1a receptor
instead of one of the adenosine receptors, are shown in
Additional file 3: Figure S3. To further confirm that Gi
binds A2AR in the receptor heteromer, the energy trans-
fer between Rluc fused to the N-terminal domain of the
α-subunit of Gi (Gi-Rluc) and A2AR-YFP was analyzed in
Fig. 2 Influence of G proteins on A1R and A2AR homodimerization and heterodimerization. B Bioluminescence resonance energy transfer (BRET)
saturation curves were performed in HEK-293T cells 48 h post-transfection with (a, c) 0.3 μg of cDNA corresponding to A1R-Rluc and increasing
amounts of A1R-YFP (0.1–1.5 μg cDNA) or GHS1a-YFP (0.25–2 μg cDNA) as negative control (a, purple line), without (a) or with (c) 0.15 μg of cDNA
corresponding to A2AR; (b, d) 0.2 μg of cDNA corresponding to A2AR-Rluc and increasing amounts of A2AR-YFP (0.1–1.0 μg cDNA) or GHS1a-YFP
(0.25–2 μg cDNA) as negative control (b, purple line), without (b) or with (d) 0.5 μg of cDNA corresponding to A1R; (e) 0.3 μg of cDNA corresponding
to A1R-Rluc and increasing amounts of A2AR-YFP (0.1–1.0 μg cDNA); and (f) 0.5 μg of cDNA corresponding to A1R (except control blue curves that were
obtained in cells not expressing A1R), 2 μg of cDNA corresponding to Gi-Rluc, and increasing amounts of A2AR-YFP (0.1–0.5 μg cDNA). In panels a, b,
and e, cells were also transfected with 0.5 μg of cDNA corresponding to the Gi-related (orange curves) or Gs-related (blue curves) minigenes. Cells were
treated for 16 h with medium (black curves), with 10 ng/ml of pertussis toxin (green curves), or with 100 ng/ml of cholera toxin (red curves) prior to
BRET determination. To confirm similar donor expressions (approximately 100,000 bioluminescence units) while monitoring the increase in acceptor
expression (1000–40,000 fluorescence units), the fluorescence and luminescence of each sample were measured before energy transfer data acquisition.
MiliBRET unit (mBU) values are the mean ± standard error of the mean of four to six different experiments grouped as a function of the amount of BRET
acceptor. In each panel (top) a cartoon depicts the proteins to which Rluc and YFP were fused and the presence or not of partner receptors and/or Gs or
Gi proteins [schemes in c to f are not intended to illustrate on stoichiometry because the predominant form in cells expressing the two receptors was
the heterotetramer containing two A1 and two A2A receptors (see “Results”)]
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hyperbolic BRET curve was observed in the presence of
A1R, but not in its absence, indicating that Gi and Gs are
bound to their respective receptor homodimers within
the A1R-A2AR heteromer.
Further, two complementary BRET experiments were
performed to determine the orientation of Gi and Gs
within the A1R-A2AR heterocomplex. First, Rluc and
YFP were respectively fused to the N-terminal domains
of the α-subunit of Gi (αi-Rluc) and Gs (αs-YFP) (Fig. 3,
bar a); second, they were fused to the N-terminal do-
main of the γ-subunit (γ-Rluc and γ-YFP) (Fig. 3, bar b).
We observed significant energy transfer between γ-Rluc
and γ-YFP in cells co-expressing A1R and A2AR (Fig. 3,
bar b) but minimal amounts in negative-control cells
(Fig. 3, bars c and d). In cells expressing either A1R or
A2AR, the energy transfer between γ-Rluc and γ-YFP
was also low (Fig. 3, bars e and f), suggesting that dimers
but not tetramers were the most prevalent form of
surface receptors in single-transfected cells. These
results in co-transfected cells corroborate the 2:2 stoichi-
ometry obtained from analysis of the fluorescence in
single particles and are consistent with Gi and Gs bind-
ing to these A1R-A2AR heterotetramers.
Molecular model of Gi and Gs bound to the A1R-A2AR
heterotetramer
To identify the orientation of the G protein in the receptor
homodimer, we combined energy transfer assays betweenFig. 3 Gs and Gi coupling to adenosine A1R-A2AR heterocomplexes. Biolumin
in HEK-293T cells 48 h post-transfection with (a, b) 0.2 μg of cDNA correspon
cDNA corresponding to A1R or 0.15 μg of cDNA corresponding to A2AR and 0
GHS1a; (e) 0.2 μg of cDNA corresponding to A1R; or (f) 0.15 μg of cDN
cDNA corresponding to the α-subunit of Gi fused to Rluc and increasing amo
0.3 μg of cDNA corresponding to the γ-subunit fused to Rluc and increasing
Maximum miliBRET unit (mBU) values are the mean ± standard error of the m
which Rluc and YFP were fused is provided (top). ***p < 0.001 by one-way ANαs-Rluc (Rluc at the N-terminus of the G protein α-
subunit) and A2AR-YFP (Fig. 4a) with information on
transmembrane (TM) interfaces based on crystal struc-
tures of GPCRs [3, 4], which have been recently sum-
marized [25]. The observed high-energy transfer using
αs-Rluc and A2AR-YFP indicated close proximity between
the N-tail of the α-subunit of Gs and the C-tail of
A2AR. Interestingly, Rluc and YFP in the “monomeric”
A2AR-Gs complex (see “Methods”) point toward
distant positions in space (Fig. 4b). Therefore, the
observed BRET should occur between Rluc in the G
protein α-subunit and a second A2AR-YFP protomer.
Among all described TM interfaces for receptor
homodimerization (see Additional file 4: Figure S4),
we propose the TM4/5 interface, which is observed in
the oligomeric structure of β1-AR [4] and in struc-
tures derived from coarse-grained molecular dynamics
(MD) simulations [26]. In fact, this is the only inter-
face that favors BRET between αs-Rluc and a second
A2AR-YFP protomer in a homodimer (Fig. 4c). The hom-
ologous A1R homodimer was built using the same TM4/5
interface as for A2AR (see Additional file 4: Figure S4 and
its legend).
The remaining possible TMs able to form heteromeric
interfaces are TM1 and TM5/6 (Fig. 5). Both are possible
inter-GPCR interfaces as observed in the structure of
the μ-opioid receptor (μ-OR) [3]. To discern between
these two possibilities, a bimolecular fluorescence com-
plementation strategy was undertaken. For this purpose,escence resonance energy transfer (BRET) experiments were performed
ding to A1R and 0.15 μg of cDNA corresponding to A2AR; (c, d) 0.2 μg of
.4 μg of cDNA corresponding to growth hormone secretagogue receptor
A corresponding to A2AR. Cells were also transfected with 2 μg of
unts of cDNA corresponding to the α-subunit of Gs fused to YFP (a) or
amounts of cDNA corresponding to the γ-subunit fused to YFP (b–f).
ean of four different experiments. A scheme showing the protein to
OVA with post - hoc Dunnett’s test
Fig. 4 Orientation of a G protein in a receptor homodimer. Bioluminescence resonance energy transfer (BRET) saturation experiments were
performed in HEK-293T cells transfected with 2 μg of cDNA corresponding to the α-subunit of Gs fused to Rluc and increasing amounts of
A2AR-YFP (0.1–0.5 μg) cDNA. a BRET measurements in cells pretreated for 16 h with medium (black line) or with 100 ng/ml of cholera toxin
(red line). Both fluorescence and luminescence of each sample were measured before every experiment to confirm similar donor expressions
(approximately 50,000 bioluminescence units) while monitoring the increase in acceptor expression (1000–10,000 fluorescence units). miliBRET
unit (mBU) values are the mean ± standard error of the mean of four to five different experiments grouped as a function of the amount of BRET
acceptor. A scheme of the placement of donor and acceptor BRET moieties is provided (top). b Molecular model of the A2AR-Gs complex. Rluc
(blue) is attached to the N-terminal αN helix of Gs (gray), and YFP (yellow) is attached to the C-terminal domain of A2AR (light green) (see Additional
file 9: Figure S9 for details). c Arrangement of A2AR homodimers modeled via the TM4/5 interface as observed in the oligomeric structure of
β1-AR [4]. The A2AR protomer bound to αs is shown in light green, whereas the second A2AR-YFP protomer is shown in dark green. The molecular
model in panel c (BRET between Rluc in Gs α subunit and YFP in a second A2AR protomer; center-to-center distance between Rluc and YFP of 6.5
nm), in contrast to the model shown in panel B (BRET between Rluc in Gs α subunit and YFP in the G-protein bound A2AR protomer; center-to-
center distance between Rluc and YFP of 8.3 nm), would favor the observed high-energy transfer (see panel a) between αs-Rluc and A2AR-YFP
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(A1R-nRluc8) and its C-terminal domain to A2AR
(A2AR-cRluc8), which only upon complementation can
act as a BRET donor (Rluc8). The BRET acceptor
protein was obtained upon complementation of the
N-terminal fragment of YFP Venus protein fused to
A1R (A1R-nVenus) and its C-terminal domain fused
to A2AR (A2AR-cVenus). When all four receptor con-
structs were transfected, we obtained a positive and
saturable BRET signal (BRETmax of 35 ± 2 mBU and
BRET50 of 16 ± 3 mBU) that was not obtained for
negative controls (Additional file 5: Figure S5).
Figure 5a, b shows that the hemi-donor (A1R-nRluc8
and A2AR-cRluc8) and the hemi-acceptor (A1R-nVe-
nus and A2AR-cVenus) moieties, placed at the C-
terminus of the receptors, can only complement if
A1R-A2AR heterodimerization occurs via the TM5/6
interface. The TM4/5 interface for homodimerization
and the TM5/6 interface for heterodimerization give a
rhombus-shaped tetramer organization (Fig. 5a).
Remarkably, cell pre-incubation with either pertussisor cholera toxins decreased the BRETmax by 35 %
(Fig. 5c), further suggesting that both Gs and Gi
proteins bind to the A1R-A2AR heterotetramer.
We next evaluated, using computational tools,
whether the proposed A1R-A2AR heterotetramer could
couple to both Gi and Gs proteins. Clearly, the exter-
nal protomers of the proposed A1R-A2AR heterotetra-
mer can bind to Gi and Gs proteins (Fig. 5d). This
model positions the α-subunits of Gi and Gs in close
contact, facing the interior of the tetrameric complex,
while the N-terminal α-helices of αi and αs point
outside the complex. The N-terminal α-helices of the
γ-subunits are in close proximity, facing the inside
(Additional file 6: Figure S6), which explains the
significant energy transfer observed between γ-Rluc
and γ-YFP (Fig. 3, bar b). The model provides experi-
mental insights into the structural arrangement of
heteromers consisting of two GPCRs and coupled to
two G proteins, the possibility of which has recently
been discussed [25]. We used MD simulations to
study the stability of this complex. Additional file 7:
Fig. 5. Bioluminescence resonance energy transfer (BRET)-aided construction of a model consisting of Gi and Gs bound to an A1R-A2AR
heterotetramer. a, b A1R-A2AR tetramer built using TM5/6 (a) or TM1 (b) inter-receptor interfaces modeled as in the structure of the μ opioid receptor
[3]. TM helices 1, 4, and 5, involved in receptor dimerization, are highlighted in dark blue, light blue, and gray, respectively. nRluc8 and cRluc8 are shown
in blue and nVenus and cVenus in dark yellow. c BRET and bimolecular fluorescence complementation experiments were performed in HEK-293T cells
transfected with 1.5 μg of cDNA corresponding to A1R-cRluc8 and A2AR-nRluc8, and 1.5 μg of cDNA corresponding to A1R-nVenus and A2AR-cVenus. As
the negative control, cells were transfected with 1 μg of cDNA corresponding to nRluc8 and 1.5 μg of cDNA corresponding to A2AR-nRluc8, A1R-nVenus,
and A2AR-cVenus. Cells were treated for 16 h with medium (– toxins), 10 ng/ml of pertussis toxin (+ pertussis), or 100 ng/ml of cholera toxin (+ cholera)
prior to BRET determination. The relative amount of BRET is given as in Fig. 4 and values are the mean ± standard error of the mean of three different ex-
periments. Student’s t-test showed statistically significant differences with respect to the control (#p< 0.05, ##p< 0.01) and a significant effect in the pres-
ence of either toxin over BRET in the absence of toxins (*p< 0.05). A schematic representation at the top shows the protein to which the hemi
luminescent or fluorescent proteins were fused. d Molecular model of the A1R-A2AR tetramer in complex with Gi and Gs. A1R bound to Gi is shown in red,
Gi-unbound A1R is shown in orange, A2AR bound to Gs is shown in dark green, Gs-unbound A2AR is shown in light green, and the α, β-, and γ-subunits of Gi
and Gs are shown in dark gray, light gray, and purple, respectively. Transmembrane helices 4 and 5 are highlighted in light blue and gray, respectively
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on protein α-carbons throughout the MD simulation,
as well as key intermolecular distances among proto-
mers and G proteins. Clearly, both the A1R protomer
bound to Gi and the A1R protomer that does not
interact with it maintained a close structural similarity
(rmsd ≈ 0.3 nm) relative to the initial structures. Similar
results were obtained for the A2AR protomers (bound and
unbound to Gs) (Additional file 7: Figure S7A). The fact
that rmsd values of the whole system, formed by the
A1R-A2AR heterotetramer bound to Gi and Gs, are of the
order of 0.6 nm indicates that the initial structural model
is maintained during the MD simulation (Additional file 7:
Figure S7A). As a consequence, selected intermolecu-
lar distances among protomers and G proteins remain
constant during the MD simulation (Additional file 7:Figure S7B). A key aspect in the assembly of the het-
erotetramer is the TM interfaces for homodimeriza-
tion (TM4/5) and heterodimerization (TM5/6).
Additional file 8: Figure S8B shows rmsd values of
the four-helix bundle forming the TM4/5 and TM5/6 in-
terfaces, the initial and final snapshots of these bundles,
and the evolution of the A1R-A2AR heterotetramer during
the MD simulation. Clearly, the rather small structural
variations of these four-helix bundles, also reflected
by rmsd <0.3 nm, suggest a stable complex. Notably,
the TM5/6 four-helix bundle seems more stable than
the TM4/5 bundles, as shown by its lower rmsd value.
Additional file 8: Figure S8B, C depicts contact maps of
the TM4/5 and TM5/6 interfaces, as well as the evolution
of the network of hydrophobic interactions within these
interfaces during the MD simulation.
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For more than a decade, experimental evidence has sup-
ported the occurrence of homo-oligomers and hetero-
oligomers of GPCRs [21]. However, our basic understand-
ing of what makes heteromers different from homomers
remains unknown. Our results, studying adenosine recep-
tors as a model heteromer, point to three important new
findings. First, the predominant stoichiometry in cells
expressing A1R-A2AR heteromers is 2:2; that is, a dimer of
dimers (tetramer). Second, two different heterotrimeric G
proteins can couple to heteromers, the overall complex
constituting a functional unit. Third, the molecular
orientation within the heteromer complex affords various
qualitatively different interfaces; the two more relevant are
the inter-protomer heteromeric interface and the inter-G-
protein interface. Presumably, the two interfaces provide
the key characteristic of heteromers: the ability of one pro-
tomer/G-protein complex to influence the signaling of the
other. Surely, allosteric effects occurring between heterore-
ceptors and between Gs and Gi proteins are due to con-
formational changes transmitted along the intimately
interacting molecules in the complex. In our controlled cell
transfection system, which expressed a low density of re-
ceptors, minor species formed by monomers and trimers
were found in addition to a predominance of tetramers in
the plasma membrane, strongly supporting the occurrence
of an in vivo dynamic distribution of receptors.
Adenosine was, from an evolutionary point of view,
one of the first extracellular regulators given that it is
involved in energy and nucleic acid metabolisms.
Adenosine A1 and A2A receptors are expressed in almost
every mammalian organ and tissue. In the heart, where
adenosine plays a key role in both inotropic and chrono-
tropic regulation, A1R-mediated cardioprotection did
not occur in A2AR knockout mice, suggesting an inter-
action between A1 and A2A receptors. In neurons, A1
and A2A receptors show co-localization, leading to inter-
receptor interactions unveiled by pharmacological treat-
ments. For instance, Okada et al. [27] showed that
cAMP-dependent protein kinase A plays a role in the
regulation of hippocampal serotonin release mediated by
both A1 and A2A receptors. Similarly, the control of γ-
amino butyric acid transport in astrocytes was attributed
to the expression of A1R-A2AR heteromers and to a
specific mechanism by which the heteromer signals via
Gi or Gs depending on the concentration of adenosine
[28]. The structural basis of the differential signaling by
the heteromer/G-protein macromolecular complex likely
implies communication at the receptor-receptor level
but also between Gs and Gi. Because the binding of two
G proteins to a heterodimer is not feasible due to steric
clashes [25], our finding that the A1R-A2AR heterotetra-
mer may bind to both Gs and Gi provides a structural
framework to interpret experimental data.Methods
Total internal reflection microscopy and single-particle
data analysis
Single-particle imaging and tracking were performed
on a Nikon Total Internal Reflection Fluorescence
(TIRF) system, as detailed in Additional file 11:
Supplementary Methods. Typically, 500 readouts of a
512 × 512-pixel region, the full array of the CCD chip,
were acquired. For single-particle data analysis, parame-
ters were calculated by applying the equations described
in Additional file 11: Supplementary Methods.
Cell culture and transient transfection
HEK-293T cells were grow at 37 °C in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco, Thermo Fischer
Scientific, Madrid, Spain) supplemented with 2 mM
L-glutamine, 100 U/ml penicillin/streptomycin, and 5
% (v/v) heat-inactivated fetal bovine serum (FBS) (all
supplements were from Invitrogen, Paisley, UK). Cells
were transiently transfected with cDNA corresponding
to receptors, fusion proteins, A2AR mutants, or G-protein
minigene vectors obtained as detailed in an expanded view
by the polyethylenimine (PEI; SigmaAldrich, Cerdanyola
del Vallès, Spain) method. Sample protein concentration
was determined using a Bradford assay kit (Bio-Rad, Mun-
ich, Germany) using bovine serum albumin dilutions as
standards. For single-particle imaging, cells were seeded
into six-well plates containing glass coverslips (No. 1,
round, 24 mm; Assistent, Sondheim, Germany) or into the
Lab-Tek Chambered #1.0 Borosilicate Coverglass System
(Nunc, Thermo Fisher Scientific, Schwerte, Germany).
Cell transient transfections were performed with Lipofec-
tamine™ 2000 (Invitrogen, Life Technologies, Darmstadt,
Germany) or FuGENE 6 (Roche Applied Science, Indian-
apolis, IN, USA) and the application of 0.1–0.2 μg plasmid
DNA per well. Before each experiment, cells were washed
three times with 200 μL phenol red-free DMEM.
Plasmids
DNA sequences encoding amino acid residues 1–155
and 155–238 of YFP Venus protein, and amino acids
residues 1–229 and 230–311 of RLuc8 protein were sub-
cloned in the pcDNA3.1 vector to obtain the YFP Venus
and RLuc8 hemi-truncated proteins. The human cDNAs
for adenosine receptors, A2AR and A1R, cloned into
pcDNA3.1, were amplified without their stop codons
using sense and antisense primers harboring unique
EcoRI and BamHI sites to clone receptors into the
pcDNA3.1RLuc vector (pRLuc-N1; PerkinElmer, Wellesley,
MA, USA), and EcoRI and KpnI to clone A2AR, A1R, or
GHS1a into the pEYFP-N1 vector (enhanced yellow variant
of GFP; Clontech, Heidelberg, Germany). Gαs cloned into
the SFV1 vector, Gαi cloned into the pcDNA3.1 vector, or
Gγ cloned into the pEYFP-C1 vector were amplified
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primers harboring unique HindIII and BamHI sites to
clone them into the pcDNA3.1-Rluc vector, or EcoRI and
KpnI to clone Gαs into the pEYFP-N1 vector. The ampli-
fied fragments were subcloned to be in-frame with restric-
tion sites of the pcDNA3.1RLuc or pEYFP-N1 vectors to
give plasmids that expressed proteins fused to RLuc or
YFP on the N-terminal end (Gαs-RLuc, Gαi-RLuc, Gγ-
RLuc, Gαs-YFP, and Gγ-YFP) or the C-terminal end (A1R-
RLuc, A2AR-RLuc, A1R-YFP, A2AR-YFP, and GHS1a-YFP).
The human cDNAs for A1R or GHS1a were subcloned
into pcDNA3.1-nRLuc8 or pcDNA3.1-nVenus to give plas-
mids that expressed A1R or GHS1a fused to either nRLuc8
or nYFP Venus on the C-terminal end of the receptor
(A1R-nRLuc8 and A1R-nVenus or GHS1a-nRLuc8 and
GHS1a-nVenus). The cDNAs for human A2A or GHS1a
receptors were subcloned into pcDNA3.1-cRLuc8 or
pcDNA3.1-cVenus to give plasmids that expressed recep-
tors fused to either cRLuc8 or cYFP Venus on the C-
terminal end of the receptor (A2AR-cRLuc8 and A2AR-
cVenus or GHS1a-cRLuc8 and GHS1a-cVenus). Expres-
sion of constructs was tested by confocal microscopy and
the receptor-fusion protein functionality by measuring
ERK1/2 phosphorylation and cAMP production, as de-
scribed previously [13, 14, 17, 29].
“Minigene” plasmid vectors are constructs designed to
express relatively short polypeptide sequences following
their transfection into mammalian cells. Here, we
used minigene constructs encoding the carboxyl-
terminal 11-amino acid residues from Gα subunits of
Gi1/2 (Gi minigene) or Gs (Gs minigene) G proteins;
the resulting peptides inhibit G-protein coupling to
the receptor and consequently inhibit the receptor-
mediated cellular responses as previously described
[24]. The cDNA encoding the last 11 amino acids of
human Gα subunit corresponding to Gi1/2 (I K N N L K
D C G L F) or Gs (Q R M H L R Q Y E L L), inserted
in a pcDNA3.1 plasmid vector, were generously pro-
vided by Dr Heidi Hamm.
Energy transfer assays
For BRET and complementation BRET assays, HEK-
293T cells were transiently cotransfected with a constant
amount of cDNA encoding for proteins fused to RLuc,
nRLuc8, or cRLuc8, and with increasing amounts of the
cDNA corresponding to proteins fused to YFP, nYFP
Venus, or cYFP Venus (see figure legends). To quantify
protein-YFP expression or protein-reconstituted YFP
Venus expression, cells (20 μg protein) were distributed
in 96-well microplates (black plates with a transparent
bottom) and fluorescence was read in a FLUOstar OP-
TIMA Fluorimeter (BMG Labtechnologies, Offenburg,
Germany) equipped with a high-energy xenon flash
lamp, using a 10 nm bandwidth excitation filter at 400nm reading. Protein fluorescence expression was
determined as the fluorescence of the sample minus the
fluorescence of cells expressing the BRET donor alone.
For BRET measurements, the equivalent of 20 μg of cell
suspension were distributed in 96-well microplates
(Corning 3600, white plates; Sigma) and 5 μM coelenter-
azine h (Molecular Probes, Eugene, OR, USA) was
added. After 1 min for BRET or after 5 min for BRET
with bimolecular fluorescence complementation, the
readings were collected using a Mithras LB 940 that
allows the integration of the signals detected in the
short-wavelength filter at 485 nm (440–500 nm) and the
long-wavelength filter at 530 nm (510–590 nm). To
quantify protein-RLuc or protein-reconstituted RLuc8
expression, luminescence readings were also performed
10 min after adding 5 μM coelenterazine h. The net
BRET was defined as [(long-wavelength emission)/
(short-wavelength emission)] – Cf, where Cf corre-
sponds to [(long-wavelength emission)/(short-wave-
length emission)] for the donor construct expressed
alone in the same experiment. BRET is expressed as
miliBRET units (mBU; net BRET × 1000).
Computational model of the A1R-A2AR tetramer in
complex with Gi and Gs
The crystal structure of inactive A2AR [PDB:4EIY] [30]
was used for the construction of human A2AR
[UniProt:P29274] and A1R [UniProt:P30542] homology
models using Modeller 9.12 [31]. These receptors share
51 % of sequence identity and 62 % of sequence similarity,
excluding the C-terminal after helix 8. Intracellular loop 3
(ICL3) of A2AR (Lys209–Gly218) and A1R (Asn212–
Ser219) were modeled using Modeller 9.12 [31] using
ICL3 of squid rhodopsin [PDB:2Z73] as a template. The
C-terminus tails of A1R, containing 16 amino acids
(Pro311–Asp326), and of A2AR, containing 102 amino
acids (Gln311–Ser412), were modeled as suggested for the
oxoeicosanoid receptor (OXER) [32] (see Additional file 9:
Figure S9 for details). The N-terminus of A1R and A2AR
were not included in the model. The “active” conforma-
tions of A1R bound to Gi and A2AR bound to Gs were
modeled using the crystal structure of β2-AR in complex
with Gs [PDB:3SN6] [33]. The globular α-helical domain
of the α-subunit was modeled in the “closed” conform-
ation [34], using the crystal structure of [AlF4
−]-activated
Gi [PDB:1AGR]. The location of YFP [PDB:2RH7] at-
tached to the C-tail of A2AR was determined as suggested
for the OXER [32] (see Additional file 9: Figure S9 for de-
tails). Rluc [PDB:2PSD] and YFP were fused to the to the
N-terminus of the α-subunits and γ-subunits of Gi and Gs
by a covalent bond. The structures of adenosine receptor
oligomers were modeled via the TM4/5 interface for
homodimerization, using the oligomeric structure of the
β1-AR [PDB:4GPO] [4], or via the TM5/6 interface for
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[PDB:4DKL] [3]. The Gi-bound A1R and Gs-bound A2AR
protomers were rotated 10° to avoid the steric clash of the
N-terminal helix of Gi and Gs with the C-terminal helix
(Hx8) of Gs-unbound A2AR and Gi-unbound A1R, re-
spectively. This computational model, without Rluc and
YFP, was placed in a rectangular box containing a lipid bi-
layer (814 molecules of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine - POPC -) with explicit solvent (102,973
water molecules) and a 0.15 M concentration of Na+ and
Cl− (1762 ions). This initial complex was energy-
minimized and subsequently subjected to a 10 ns MD
equilibration, with positional restraints on protein coordi-
nates. These restraints were released and 500 ns of MD
trajectory were produced at constant pressure and
temperature (see Additional file 10: Movie M1). Computer
simulations were performed with the GROMACS 4.6.3
simulation package [35], using the AMBER99SB force
field as implemented in GROMACS and Berger parame-
ters for POPC lipids. This procedure has been previously
validated [36].
Availability of data and materials
The crystal structures 4EIY, 2Z73, 3SN6, 1AGR, 2RH7,
2PSD, 4GPO, and 4DKL are available from PDB (http://
www.rcsb.org). All other relevant data are within the
paper and its Additional files.
Additional files
Additional file 1: Figure S1. Examples of receptor trajectories in
HEK-293T cells. Images of cells expressing A1R-GFP (A) and of particular
trajectories of A1R-GFP-containing (B) or A2AR-mCherry-containing (C)
particles. (TIF 1164 kb)
Additional file 2: Figure S2. Graphical description of the stoichiometry
of A1R-GFP, A2AR-mCherry or both A1-GFP and A2A-mCherry. The
fluorescence intensity signal distribution (gray area) detected for more than
7000 independent observations is given for HEK-293T cells expressing
A1-GFP (A), A2A-mCherry (D), or both A1-GFP and A2A-mCherry (B, E). The
stoichiometry analysis was performed for A1-GFP (A, B) and A2A-mCherry
(D, E). Curves approximately delineating the amount of monomers, dimers,
trimers, and tetramers are displayed in green for A1-GFP (A, B) and in red
for A2A-mCherry (D-E). The occurrence on the cell surface of monomers, di-
mers, trimers, and tetramers for A1-GFP (C) expressed alone (black bars) or in
the presence of A2A-mCherry (blue bars) and for A2A-mCherry (F) expressed
alone (black bars) or in the presence of A1-GFP (blue bars) was calculated by
stoichiometry analysis from results shown in A, B, D, and E. (TIF 455 kb)
Additional file 3: Figure S3. Controls of cAMP production and BRET
assays in cells expressing minigenes and in cells expressing the ghrelin
GHS1a receptor instead of one of the adenosine receptors. (A,B) cAMP
determination in HEK-293T cells transfected with (A) 0.3 μg of cDNA
corresponding to A1R or (B) with 0.2 μg of cDNA corresponding to A2AR
with (control) or without 0.5 μg of cDNA corresponding to minigenes
coding for peptides blocking either Gi or Gs binding. Cells were stimulated
with the A1R agonist N
6-Cyclopentyladenosine (CPA) (10 nM, red bars) in the
presence of 0.5 μM forskolin (Fk) or with the A2AR agonist 4-[2-[[6-Amino-9-(N-
ethyl-β-D-ribofuranuronamidosyl)-9H-purin-2-yl]amino]ethyl]benzenepropanoic
acid hydrochloride (CGS-21680) (200 nM, blue bars). Values expressed as % of
the forskolin-treated cells (CPA reduces forskolin-induced cAMP levels, red
bars) or of the basal (CGS 21680 per se enhances cAMP levels, blue bars) aregiven as mean ± SD (n = 4–8). One-way ANOVA followed by a Bonferroni post
- hoc test showed a significant effect of CPA when compared with that of
forskolin (red bars, ***p< 0.001) or of CGS 21680 when compared to basal
cAMP levels (blue bars, ##p< 0.01, ###p< 0.001). (C, D) BRET saturation curves
were performed in HEK-293T cells transfected with (C) 0.3 μg cDNA coding for
A1R-Rluc, increasing amounts of cDNA coding for A1R-YFP (0.1–1.5 μg cDNA),
and 0.4 μg cDNA coding for GHS1a, or (D) with 0.2 μg of cDNA coding for
A2AR-Rluc, increasing amounts of cDNA coding for A2AR-YFP (0.1–1.0 μg
cDNA), and 0.5 μg cDNA coding for to GHS1a. Prior to BRET determination,
cells were treated for 16 h with medium (black curves), with 10 ng/ml of
pertussis toxin (green curves), or with 100 ng/ml of cholera toxin (red
curves). mili BRET units (mBU) are given as the mean ± SD (n = 4–6
different experiments grouped as a function of the amount of BRET
acceptor). (TIF 1418 kb)
Additional file 4: Figure S4. Possible interfaces in A2AR homodimers in
complex with Gs. In A–E, the A2AR homodimer was modeled through
TM4 using the H1-receptor structure as template (A), through TM5 using
the structure of squid rhodopsin (B), through TM4/5 using the β1-
receptor structure (C), and via TM5/6 (D) and TM1 (E) using the μ-OR
structure. TM helices 1, 4, and 5 involved in receptor dimerization are
highlighted in dark blue, light blue, and gray, respectively. A2AR protomers
bound to Gs (in gray) are shown in light green, whereas Gs-unbound A2AR
protomers are shown in dark green. Rluc (blue) is attached to the N-
terminal αN helix of Gs, and YFP (yellow) is attached to the C-terminal
domain of the Gs-unbound A2AR protomer (light green). It is important to
note that the position of YFP is highly dependent on the orientation of the
long and highly flexible C-tail of A2AR (102 amino acids, Gln311–Ser412),
which was modeled as described for the OXER [32] (see Additional file 9:
Figure S9 for details). Despite these limitations, we can crudely estimate the
approximate distances between the center of mass of Rluc and YFP as 4.6,
10.1, 6.5, 11.6, and 8.3 nm for panels A–E, respectively. Thus, among all these
possible dimeric interfaces, only the molecular models depicted in panels A
(TM4 interface) and C (TM4/5 interface) would favor the observed high-
energy transfer between Gs-Rluc and A2AR-YFP (Fig. 4a in main paper).
However, there is a steric clash between the N-terminal helix of Gs and the
dark-green protomer in the TM4 interface. Accordingly, we have modeled
A2AR homodimerization via the TM4/5 interface. Unfortunately, similar
experiments with cells transfected with Gi-Rluc and A1R-YFP could not be
accomplished because of a lack of receptor expression (not shown); it is
likely that the shorter C-tail of A1R (16 amino acids, Pro311–Asp326) could
not accommodate YFP in the presence of Gi in the right three-dimensional
structure. The A1R homodimer was built using the same TM4/5 interface as
for A2AR. (TIF 3135 kb)
Additional file 5: Figure S5. BRET assays in cells expressing fusion
proteins containing hemi-Rluc8 and hemi-Venus moieties fused to
adenosine receptors or containing the ghrelin GHS1a receptor instead
of one of the adenosine receptors. (A) Saturation BRET curve in HEK-293T
co-transfected with 1.5 μg of the two cDNAs corresponding to
A1R-cRLuc8 and A2AR-nRLuc8 and with increasing amounts of cDNAs
corresponding to A1R-nVenus and A2AR-cVenus (equal amounts of the
two cDNAs). BRETmax was 35 ± 2 mBU and BRET50 was 16 ± 3 mBU.
BRET in cells expressing cRluc8 instead of A1R-cRluc8 gave a linear,
non-saturable signal. (B) Comparison of BRET responses using
complementary and non-complementary pairs, or replacing one
adenosine receptor with the ghrelin GHS1a (gn) receptor. Data are mean ±
SD of three different experiments grouped as a function of the amount
of BRET acceptor. ***p < 0.001 with respect to BRET in cells expressing
adenosine receptors and hemi-Rluc8 and hemi-Venus proteins. (TIF 398 kb)
Additional file 6: Figure S6. Details of the relative position of Rluc and
YFP in a receptor heterotetramer interacting with two G proteins.
Computational-based model of Gs and Gi bound to the adenosine A1R-
A2AR heterotetramer. Rluc and YFP fused to the N-terminal domain of the
Gα-subunits point toward different positions in space (A), whereas Rluc
and YFP fused to Gγ-subunits are close (B). The color code of the proteins
is depicted in the adjacent schematic representations (TM4 and TM5 of
GPCR protomers are in light blue and gray, respectively). (TIF 6445 kb)
Additional file 7: Figure S7. Molecular dynamics (MD) simulation of
the adenosine A1R-A2AR heterotetramer in complex with Gi and Gs.
(A) Root-mean-square deviations (rmsd) on protein α-carbons of the
whole system (black solid line), of the two A1Rs (orange and red
Navarro et al. BMC Biology  (2016) 14:26 Page 11 of 12solid lines), of the two A2ARs (light and dark green solid lines), of Gi
(gray solid line), and of Gs (gray dotted line) throughout the MD
simulation. This color scheme matches with the color of the different
proteins depicted in the two adjacent schematic representations. (B)
Intermolecular distances between the N-terminal helices of the γ-subunit of
Gi and Gs (magenta line), the N-terminal helices of the α-subunit of Gi and
Gs (gray line), the N-terminal helix of the α-subunit of Gi and the C-terminal
helix (Hx8) of inactive A1R (orange line), the N-terminal helix of the
α-subunit of Gs and the C-terminal Hx8 of inactive A2AR (green line), the
C-terminal Hx8 of A1R and A2AR (blue lines). These computed intermolecular
distances are depicted as double arrows in the two adjacent schematic
representations. (TIF 6973 kb)
Additional file 8: Figure S8. Evolution of TM4/5 and TM5/6 interfaces as
devised from MD simulations of the adenosine A1R-A2AR heterotetramer in
complex with Gi and Gs. (A) Representative snapshots (20 structures
collected every 25 ns) of the TM domains of A1R bound to Gi (red), Gi-
unbound A1R (orange), A2AR bound to Gs (dark green), and Gs-unbound
A2AR (light green). TM helices 4 and 5 are highlighted in light blue and gray,
respectively. Initial (at 0 ns, transparent cylinders) and final (at 500 ns, solid
cylinders) snapshots of TM interfaces are shown for homodimerization
(TM4/5, within rectangles) and heterodimerization (TM5/6, within a circle)
bundles. TM helices 4 (light blue), 5 (gray), and 6 (orange and green) are
highlighted. (B) Root-mean-square deviations (rmsd) on protein α-carbons
of the four-helix bundles forming the TM5/6 interface (orange solid line),
TM4/5 interface of A1R (blue dotted line), and TM4/5 interface of A2AR (blue
solid line) throughout the MD simulation. (C) Contact maps of the TM4/5
interface (rectangles in panel A) in the A1R or A2AR homodimer (left and
right panels) and of the TM5/6 interface (circle in panel A) in the A1R-A2AR
heterodimer (middle panel). Darker dots show more frequent contacts. (D)
Detailed view of the extensive network of hydrophobic interactions (mainly
of aromatic side chains) within the TM4/5 (left and right panels) and TM5/6
(middle panel) interfaces. The amino acids are numbered following the
generalized numbering scheme of Ballesteros and Weinstein [37, 38].
This allows easy comparison among residues in the 7TM segments of
different receptors. (TIF 4004 kb)
Additional file 9: Figure S9. Positioning YFP in the C-tail of A2AR. The
complex between the A2AR protomer (in light green) and Gs (α-subunit
in dark grey and yellow, β-subunit in light gray, and γ-subunit in purple)
was constructed from the crystal structure of β2 in complex with Gs [33].
Although the exact conformation of the A2AR C-tail (102 amino acids,
Gln311–Ser412) cannot unambiguously be determined, its orientation
was modeled as in the C-tail of squid rhodopsin [39], which contains the
conserved amphipathic helix 8 that runs parallel to the membrane and
an additional cytoplasmic helix 9. Thus, the C-tail of A2AR expands (see
solid light green line) and points intracellularly toward the N-termini of
the γ-subunit as suggested for OXER [32]. The laboratory of Kostenis has
shown that the C-terminal of OXER, labeled with Rluc (OXER-Rluc), gets
close to the N-terminal of the γ-subunit, labeled with GFP (γ-GFP) [32].
Analogously, we propose that YFP attached to the C-tail of A2AR is
positioned near the N-termini of the γ-subunit (in purple). (TIF 2395 kb)
Additional file 10: Movie M1. Assembly of adenosine A1 and A2A
receptors in complex with two G proteins and MD simulation of the
system. The assembly of Gs and Gi bound to the adenosine A1R-A2AR
heterotetramer was subjected to 500 ns of MD simulation in a
rectangular box containing the system, the lipid bilayer, explicit solvent,
and ions. A1R protomers are in orange and red, A2AR protomers in light
and dark green, Gα in white, Gβ in gray, and Gγ in purple. For easier
visualization of protomer-protomer interfaces, TMs 4 and 5 are
highlighted in blue and white, respectively. (MPEG 87870 kb)
Additional file 11: Supplementary methods. (DOCX 72 kb)
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